CRISPR ended 2023 with a bang.In November, the gene editing tool scored its first clinical approval for treating sickle cell anemia and beta-thalassemia in...
DUBLIN–(BUSINESS WIRE)–The “Nutraceuticals Market – Global Outlook & Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering.
The global nutraceuticals market is expected to grow...
One inescapable word dominated biomedicine this year: Ozempic.Physicians were amazed at the drug’s efficacy in treating diabetes, for which it is FDA approved, and...
Large language model (LLM) training has become increasingly popular over the last year with the release of several publicly available models such as Llama2,...
CRISPR has a problem: an embarrassment of riches.Ever since the gene editing system rocketed to fame, scientists have been looking for variants with better...
Machine Learning in Healthcare: The Future Of Healthcare Will Be Around ML
ML In Healthcare: Application, Benefits, and App Development Cost
Machine Learning (ML) is one...
CRISPR-based therapies just hit another milestone.In a small clinical trial with 10 people genetically prone to dangerously high levels of cholesterol, a single infusion...
Sponsored Feature As the technology becomes more widely deployed across more vertical sectors and industries, the capacity of artificial intelligence (AI) to transform business...